foscarnet and Furrow Keratitis studies

foscarnet and Furrow Keratitis

foscarnet has been researched along with Furrow Keratitis in 3 studies

Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.

Research Excerpts

Excerpt	Relevance	Reference
"Twenty patients with dendritic keratitis were treated in a double-blind analysis study with either phosphonoformate 3% or trifluorthymidine 1% drops."	2.67	Phosphonoformate (foscarnet, PFA) versus trifluorthymidine in the treatment of keratitis dendritica in the human. A double-blind, randomized, preliminary trial. ( Behrens-Baumann, W, 1992)

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	2 (66.67)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

1 (33.33)

18.7374

1990's

2 (66.67)

18.2507

2000's

0 (0.00)

29.6817

2010's

0 (0.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Alenius, S	1
Laurent, U	1
Oberg, B	1
Behrens-Baumann, W	1
Charles, SJ	1
Gray, JJ	1

Studies

Alenius, S

Laurent, U

Oberg, B

Behrens-Baumann, W

Charles, SJ

Gray, JJ

Trials

1 trial available for foscarnet and Furrow Keratitis

Article	Year
Phosphonoformate (foscarnet, PFA) versus trifluorthymidine in the treatment of keratitis dendritica in the human. A double-blind, randomized, preliminary trial. Acta ophthalmologica, 1992, Volume: 70, Issue:5 Topics: Adult; Cornea; Double-Blind Method; Follow-Up Studies; Foscarnet; Humans; Keratitis, Dendritic; Opht	1992

Article

Year

Phosphonoformate (foscarnet, PFA) versus trifluorthymidine in the treatment of keratitis dendritica in the human. A double-blind, randomized, preliminary trial.

Acta ophthalmologica, 1992, Volume: 70, Issue:5

Topics: Adult; Cornea; Double-Blind Method; Follow-Up Studies; Foscarnet; Humans; Keratitis, Dendritic; Opht

1992

Other Studies

2 other studies available for foscarnet and Furrow Keratitis

Article	Year
Effect of trisodium phosphonoformate and idoxuridine on experimental herpes simplex keratitis in immunized and non-immunized rabbits. Acta ophthalmologica, 1980, Volume: 58, Issue:2 Topics: Animals; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Idoxuridine; Keratitis, Dendritic;	1980
Ocular herpes simplex virus infections: reduced sensitivity to acyclovir in primary disease. The British journal of ophthalmology, 1990, Volume: 74, Issue:5 Topics: Acyclovir; Antiviral Agents; Foscarnet; Ganciclovir; Humans; Idoxuridine; Keratitis, Dendritic; Micr	1990

Article

Year

Effect of trisodium phosphonoformate and idoxuridine on experimental herpes simplex keratitis in immunized and non-immunized rabbits.

Acta ophthalmologica, 1980, Volume: 58, Issue:2

Topics: Animals; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Idoxuridine; Keratitis, Dendritic;

1980

Ocular herpes simplex virus infections: reduced sensitivity to acyclovir in primary disease.

The British journal of ophthalmology, 1990, Volume: 74, Issue:5

Topics: Acyclovir; Antiviral Agents; Foscarnet; Ganciclovir; Humans; Idoxuridine; Keratitis, Dendritic; Micr

1990